HUT60504A - Process for producing new adenosine derivatives and pharmaceutical compositions comprising such compounds - Google Patents

Process for producing new adenosine derivatives and pharmaceutical compositions comprising such compounds Download PDF

Info

Publication number
HUT60504A
HUT60504A HU921080A HU108092A HUT60504A HU T60504 A HUT60504 A HU T60504A HU 921080 A HU921080 A HU 921080A HU 108092 A HU108092 A HU 108092A HU T60504 A HUT60504 A HU T60504A
Authority
HU
Hungary
Prior art keywords
carbonate
alkyl
deoxy
ethylamide
formula
Prior art date
Application number
HU921080A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9201080D0 (en
Inventor
Fulvio Gadient
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of HU9201080D0 publication Critical patent/HU9201080D0/hu
Publication of HUT60504A publication Critical patent/HUT60504A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
HU921080A 1990-08-16 1991-08-13 Process for producing new adenosine derivatives and pharmaceutical compositions comprising such compounds HUT60504A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025879A DE4025879A1 (de) 1990-08-16 1990-08-16 Neue adenosin derivate, deren herstellung und verwendung

Publications (2)

Publication Number Publication Date
HU9201080D0 HU9201080D0 (en) 1992-06-29
HUT60504A true HUT60504A (en) 1992-09-28

Family

ID=6412310

Family Applications (1)

Application Number Title Priority Date Filing Date
HU921080A HUT60504A (en) 1990-08-16 1991-08-13 Process for producing new adenosine derivatives and pharmaceutical compositions comprising such compounds

Country Status (11)

Country Link
EP (1) EP0496852A1 (enExample)
JP (1) JPH05502889A (enExample)
AU (1) AU638600B2 (enExample)
CA (1) CA2064869A1 (enExample)
CS (1) CS97892A3 (enExample)
DE (1) DE4025879A1 (enExample)
FI (1) FI921691A0 (enExample)
HU (1) HUT60504A (enExample)
PL (1) PL294368A1 (enExample)
TW (1) TW197448B (enExample)
WO (1) WO1992003463A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007904A1 (en) * 1992-10-01 1994-04-14 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
GB9301000D0 (en) * 1993-01-20 1993-03-10 Glaxo Group Ltd Chemical compounds
CN114437159B (zh) * 2022-04-11 2022-06-28 佛山市晨康生物科技有限公司 一种环状碳酸酯核苷类化合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
DE3406533A1 (de) * 1984-02-23 1985-08-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
AU579412B2 (en) * 1984-10-26 1988-11-24 Warner-Lambert Company N` - substituted adenosines

Also Published As

Publication number Publication date
CS97892A3 (en) 1992-08-12
HU9201080D0 (en) 1992-06-29
WO1992003463A1 (de) 1992-03-05
CA2064869A1 (en) 1992-02-17
PL294368A1 (en) 1993-06-28
JPH05502889A (ja) 1993-05-20
EP0496852A1 (de) 1992-08-05
AU638600B2 (en) 1993-07-01
FI921691A7 (fi) 1992-04-15
FI921691A0 (fi) 1992-04-15
DE4025879A1 (de) 1992-02-20
TW197448B (enExample) 1993-01-01
AU8303291A (en) 1992-03-17

Similar Documents

Publication Publication Date Title
KR970000241B1 (ko) 플루오로 시티딘 유도체
US4948786A (en) Composition for treatment of ischemic disorder in organs
NZ250414A (en) Substituted 5'-deoxy-5-fluorocytidines and pharmaceutical compositions
EP0670314A1 (en) Farnesyltransferase inhibitor
IE60328B1 (en) Improvements in the treatment of tumors in mammals
HU208832B (en) Process for producing purinylphosphonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
US6599943B1 (en) Use of hydroxyguanidines
WO2023154528A1 (en) Stereoselective technologies for chiral compounds
HU201955B (en) Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions comprising such compounds
EP2364086B1 (en) Novel antithrombotic diadenosine tetraphosphates and related analogs
EP0328111A2 (en) Cancer cell metastasis inhibitors
BE1001621A3 (fr) Nouveaux derives de l'acide furannuronique, leur preparation et leur utilisation comme medicaments.
DE69128626T2 (de) Enzyminaktivatoren
BE1003632A3 (fr) Nouveaux derives de l'adenosine, leur preparation et leur utilisation comme medicaments.
HUT60504A (en) Process for producing new adenosine derivatives and pharmaceutical compositions comprising such compounds
US3706728A (en) N(6)-branched chain lower-alkyl-adenosine derivatives
US3212954A (en) Nucleoside-5'-sulfoxides
JPS6218545B2 (enExample)
EP0430025A2 (en) Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
FR2571374A1 (fr) Nouveaux derives de 5-fluoro-2'-desoxyuridine et leurs sels, leur procede de preparation, et agents antitumoraux les contenant
EP0942915B1 (en) Pharmaceutical formulations
JPS5940400B2 (ja) 新規ｄ−アロ−ス誘導体及びこれを有効成分とする抗腫瘍剤
US4086343A (en) Acylated hydrazinopyridazine antihypertensives
EP0042162A2 (en) Compositions for treating diseases in circulatory organs
US4016262A (en) Therapeutic compositions and methods employing N(6)-disubstituted adenosine compounds

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee